Diabetes Mellitus remains a growing problem worldwide and the scientific community continues to search for ways to prevent, slow down the progression, control and treat this complex hormonal/metabolic disease. In order to understand this, a basic overview of hormones and their effects in the body (Science of Endocrinology) needs to be elaborated—so let us start with […]

EIi Lilly and Company and Amylin Pharmaceuticals, Inc. recently announced that the European Commission has granted marketing authorization for Byetta (exenatide) for the treatment of type 2 diabetes. Exenatide is now approved in the European Union as adjunctive therapy to improve blood sugar control in patients with type 2 diabetes who have not achieved adequate […]